Proton pump inhibitor therapy is well tolerated at standard doses; even a fivefold increase in the AUC of PPIs appears to cause only negligible side effects. The clinical relevance of these ...
Proton pump inhibitors (PPIs), widely prescribed for acid-related disorders like GERD and peptic ulcers, are associated with significant adverse effects when used long-term. This review highlights ...
Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...
Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...
Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...
The use of proton pump inhibitors with anti-cancer therapies was associated with worse survival outcomes in patients with breast cancer. Concomitant use of proton pump inhibitors and other everyday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results